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Abstract 
In this study we examined the hypothesis that 17/3-estradiol exerts both rapid and direct, nongenomtc effects on cells in the 
endochondral pathway. To do this, we used a cell culture model in which chondrocytes at two distinct stages of cell maturation are 
isolated from the costochondral cartilage of male and female rats, and examined the short-term effect of 17c~- and 17fl-estradiol on 
[14C]arachidonic acid turnover in the cell layer and phospholipase A 2 specific activity in plasma membranes and extracellular matrix 
vesicles isolated from similarly prepared cultures. In addition, the effect of 17a- and 17/3-estradiol n plasma membrane and matrix 
vesicle membrane fluidity was assessed. The effect of hormone on arachidonic acid turnover was rapid, time- and concentration-depen- 
dent, stereo-specific, and cell maturation-specific. Only resting zone cells from female rats were affected, and only 17fl-estradiol elicited a 
response. Similarly, only female rat resting zone chondrocytes xhibited a change in phospholipase A 2 activity after a 24 h exposure to 
hormone, causing an increase in enzyme activity in the matrix vesicles, but not plasma membranes. When isolated membranes were 
incubated irectly with hormone, membrane fluidity was decreased in both plasma membranes and matrix vesicles isolated from female 
rat resting zone chondrocyte cultures. This nongenomic effect was dose-dependent a d stereo-specific and differentially expressed in the 
two membrane fractions with respect o time course and magnitude of response. These results support he hypothesis that 17/3-estradiol 
has a rapid action on chondrocyte membrane lipid metabolism and suggest hat specific membrane components, characteristic of a 
particular sex and state of cell maturation, are involved in the nongenomic effects of this sex hormone on isolated matrix vesicles and 
plasma membranes. 
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1. Introduction 
It is widely accepted that sex hormones influence mam- 
malian growth and development and that many of the 
effects of estrogens are indirect and mediated by other 
hormones and local factors secreted by cells in response to 
hormone stimulation [1-3]. Further, it is becoming increas- 
ingly clear from both in vivo and in vitro studies that 
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estrogens exert direct effects on cells as well. In cartilage, 
it is known that 17/3-estradiol inhibits chondrocyte prolif- 
eration [4-8] and stimulates RNA synthesis [8,9], sulfate 
incorporation [10,11], collagen production [8,10], and alka- 
line phosphatase [8,9] and creatine kinase [12] specific 
activities. In addition, many of these effects are gender- 
specific [7-11,13-16] and cell maturation-dependent 
[8,10]. 
It has been traditionally accepted that estrogens mediate 
their effects through classic steroid hormone receptor 
mechanisms. According to this view, following binding of 
17/3-estradiol to the receptor, the hormone-receptor com- 
plex undergoes translocation to the nucleus, which results 
2 Z. Schwartz et al./Biochimica et Biophysica Acta 1282 (1996) 1-10 
in gene transcription and protein synthesis [17]. Specific 
receptors for estrogens have been found in articular carti- 
lage [18,19], growth plate [16,20], and fracture callus [21]. 
Recent evidence also suggests that some of the effects 
of steroid hormones may be mediated by rapid, 
membrane-mediated mechanisms [22-25]. While some of 
these effects result in genomic regulation, others appear to 
be nongenomic, that is, those actions by a regulatory factor 
which occur via membrane receptors or as a result of the 
membrane's composition, eliciting effects that are indepen- 
dent of direct interaction with the genome. In general, 
studies of nongenomic effects use time course experiments 
to establish the nature of the response, based on the 
supposition that changes which occur within the first few 
minutes of exposure to a regulatory agent happen too 
quickly to involve genomic participation. Unless rigor- 
ously shown not to elicit new gene transcription, however, 
these rapid effects may be nonreceptor-mediated, but not 
necessarily nongenomic. To resolve this, another com- 
monly used approach is to pharmacologically block gene 
transcription or protein translation. 
Studies examining the response of rat costochondral 
chondrocytes to 1,25-(OH)2D 3 and 24,25-(OH)2D 3 have 
resulted in a model capable of assessing the nongenomic 
action of lipophilic hormones. In culture, these cells pro- 
duce matrix vesicles, extracellular organelles associated 
with matrix calcification, which have been postulated to be 
regulated in the matrix via the nongenomic action of local 
mediators [22]. Supporting this hypothesis i  the fact that 
addition of vitamin D metabolites to isolated matrix vesi- 
cles produces effects on alkaline phosphatase and phospho- 
lipase A 2 specific activities that are comparable to those 
observed in intact cultures [26,27]. Since isolated matrix 
vesicle preparations contain no DNA or RNA [28], there is 
no possibility for gene transcription or translation. The 
observation that 1,25-(OH)2D 3 and 24,25-(OH)2D 3 alter 
the phospholipid metabolism and fluidity of isolated mem- 
branes in a metabolite-specific, membrane-dependent man- 
ner [26,29] suggests that physical changes in the mem- 
brane, such as altered permeability and ion transport [22], 
might provide a mechanism explaining the nongenomic 
action of these hormones on chondrocyte cultures. Mem- 
brane receptors may account for specific membrane-media- 
ted effects, as well. 
Estradiol has been shown to alter the membrane fluidity 
of vaginal epithelial cells [30] indicating that this sex 
hormone may also exert some of its effects in cartilage via 
nongenomic regulatory pathways. This has been supported 
by the observation that estradiol exerts rapid effects in a 
variety of cell types [31,32]. Recent studies suggest hat a 
membrane receptor for estradiol [33] may be responsible 
for mediating some of the rapid effects of this hormone. 
To test the hypothesis that estradiol can act via nonge- 
nomic mechanisms, we used the same rat chondrocyte 
model used for our vitamin D studies in which cells at two 
distinct stages of cell maturation are isolated from two 
different zones of costochondral cartilage [22,27,28]. By 
use of this culture system, we can determine the sex 
specificity of the effect by examining chondrocytes from 
male and female rats. In addition, we can examine mem- 
brane specificity by comparing the effect of hormone 
treatment on isolated plasma membranes, matrix vesicles 
and intact cultures. In the present study, we determined 
whether 17/3-estradiol has a rapid action on cell membrane 
lipid metabolism and if 17/3-estradiol has a nongenomic 
effect on isolated plasma membranes and matrix vesicles 
by exposing them to hormone and assessing changes in 
membrane fluidity. 
2. Materials and methods 
2.1. Chondrocyte cultures 
The culture system used in this study has been de- 
scribed in detail before [22,26,27]. Rib cages were re- 
moved from 125 g Sprague-Dawley female and male rats 
and placed in Dulbecco's modified Eagle's medium 
(DMEM). The resting zone and growth zone cartilage was 
separated, sliced, and incubated overnight in DMEM. Cells 
were released from the tissue by sequential incubations in 
trypsin and collagenase and collected by centrifugation. 
Cultures were seeded at a density of 10000 cells/cm 2 for 
resting zone cells and 25 000 cells/cm 2 for growth zone 
cells and incubated in DMEM containing 10% fetal bovine 
serum (FBS) and 50 ~g/ml  vitamin C at 37°C in an 
atmosphere of 5% CO z and 100% humidity. Media were 
changed at 24 h and then at 72 h intervals. At confluence, 
cells were subcultured using the same plating densities and 
allowed to return to confluence. Fourth passage cells were 
used since prior studies have shown that differential re- 
sponse to vitamin D 3 metabolites is preserved at this 
passage [22,26-29,34]. 
2.2. Determination of arachidonic acid turnover 
Hormone effects on chondrocyte phospholipid 
metabolism were assessed by measuring arachidonic acid 
turnover, as previously described [29,35]. Confluent, fourth 
passage growth zone and resting zone chondrocytes were 
pre-labeled by adding [1-Z4C]arachidonic a id (0.05 /zCi; 
50 mCi/mmol, NEC-661; New England Nuclear/DuPont, 
Boston, MA) to the cultures for 60 min and the unbound 
label removed by washing. Cultures were then incubated 
for 60 min in 5 ml fresh DMEM containing 10% FBS. 
p-Chloromercuribenzoate (100 nmol/ml DMEM) (Sigma, 
St. Louis, MO) was added to half of the cultures to block 
reacylation and the incubation continued for an additional 
60 min. At this time (time 0), 17/3-estradiol was added to 
the medium and the incubation continued for up to 360 
min. Since the concentration of 17fl-estradiol in normal 
serum ranges from 10 -9 tO 10 -8 M, we chose to test 
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17/3-estradiol at both physiological and pharmacological 
concentrations ranging from 10 -~2 to 10-6M. In parallel 
experiments, the inactive metabolite, 17a-estradiol, was 
used as a control. Both hormones were dissolved in abso- 
lute ethanol and diluted by at least 1000-fold. At 5, 15, 30, 
60, 120, 180, 270 and 360 min, 50 /xl aliquots of culture 
media were collected and the reaction stopped by addition 
of 5 ml chloroform: methanol (2: 1, v/v). The 'percent 
release' of [14C]arachidonic acid was calculated as the 
amount of [ ~4C]arachidonic acid released into the medium 
in the presence of p-chloromercuribenzoate at the speci- 
fied time point divided by the total [l~C]arachidonic a id 
in the cell layer and medium at harvest at 360 min. This 
experimental design permits measurement of acylation and 
reacylation on the same population of cells. As a result, 
any incorporation of [~4C]arachidonate is the result of 
reacylation, since the only source of this fatty acid is the 
pre-labeled cell itself. 
2.3. Determination of phospholipase A z activity 
Confluent, fourth passage chondrocyte cultures were 
incubated for 24 h with medium containing vehicle or 
10- ~ J - 10- 7 M 17/3-estradiol. After treatment, conditioned 
media were discarded and the cells harvested by trypsin 
digestion. Matrix vesicles were isolated from the trypsin 
digest and plasma membranes from cell homogenates a  
described below. 
Phospholipase A 2 (EC 3.1.1.4) activity in plasma mem- 
branes and matrix vesicles was measured as a function of 
release of [~4C]arachidonate from L-a-l-palmitoyl,2- 
arachidonyl phosphatidylethanolamine (PEC; cat. #NEC- 
783, 50 mCi/mmol; New England Nuclear/DuPont, 
Boston, MA), as previously described [34]. Phospholipase 
A 2 activity was calculated as the percent hydrolysis of 
[~4C]arachidonate from the total 14C-PEC. 
2.4. Preparation of membrane fractions 
Matrix vesicles and plasma membranes were isolated 
from chondrocyte cultures as previously described [27]. 
Matrix vesicles were isolated by differential centrifugation 
of trypsin digests of the cell layer. Plasma membranes 
were isolated from cell homogenates by differential cen- 
trifugation, followed by sucrose density gradient centrif- 
ugation. The protein content of each fraction was deter- 
mined [36]. Alkaline phosphatase specific activity [37] of 
each membrane preparation was assayed to ensure that 
matrix vesicles exhibited greater than a two-fold enrich- 
ment over their respective plasma membrane fraction 
[22,27]. 
2.5. Membrane fluidity 
Membrane fluidity was assessed by using the lipophilic 
fluorophore, 1 -[4-(trimethylamine)phenyl]-6-phenyl-hexa- 
1,3,5-triene (TMP-DPH) as previously described [29,38]. 
This probe has a high quantum yield, localizes with the 
phospholipid polar head groups, and is thought o be more 
selective than its parent compound DPH [39]. TMP-DPH 
labels solely those membranes that are in contact with the 
external medium [40]. It incorporates very rapidly into the 
cell membrane and remains localized in it for at least 30 
min [41]. However, after this time, cell damage and inter- 
nalization of the probe are possible. For these reasons, 
samples were exposed to low concentrations of the probe 
for time periods not exceeding 30 min. 
In order to determine the direct effect of 17/3-estradiol 
on membrane fluidity, matrix vesicles and plasma mem- 
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Fig. 1. Effect of 17fl-estradiol on arachidonic acid turnover by resting 
zone chondrocytes derived from female rats. Confluent, fourth passage 
resting zone chondrocytes were pre-labeled with [14C]arachidonic acid 
and then treated with varying concentrations of 17fl-estradiol (10-12- 
10 -6 M) for 30, 90, or 270 min. Reacylation was blocked in one half of 
the cultures by inclusion of 100 nmol/ml p-chloromercuribenzoate. A: 
percent arachidonic acid release. B: percent arachidonic acid incorpora- 
tion. All values are from one experiment and represent the mean + SEM 
for six samples. Each experiment was repeated two or more times to 
verify the observations. * P < 0.05, treatment vs. untreated control. 
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Fig. 2. Treatment:control atios showing the effect of 17/3-estradiol 
treatment on arachidonic acid turnover by resting zone chondrocytes 
derived from female rats. Confluent, fourth passage resting zone chondro- 
cytes were pre-labeled with [t4C]arachidonic acid and then treated with 
varying concentrations of 17/3-estradiol (10-it _10-s M) for up to 360 
min. Only data for treatment with 10 -t° and 10-gM 17/3-estradiol is
shown for clarity. Reacylation was blocked in one half of the cultures by 
inclusion of 100 nmol/ml p-chloromercuribenzoate. A: percent arachi- 
donic acid release. B: percent arachidonic acid incorporation. Values 
represent the mean 5: SEM for treatment/control ratios of three separate 
experiments. * P < 0.05, treated vs. a treatment:control ratio of 1. 
branes were isolated f rom cultures not previously exposed 
to exogenous  hormone.  Membrane  fract ions (15 /zg  matr ix  
vesic le or p lasma membrane prote in / tube)  were incubated 
in 3 ml HBSS conta in ing 10% FBS plus vehic le alone or 
10 -9 or 10 -1° M of  17a- or 17/3-estradiol for the speci- 
f ied time. These concentrat ions of  hormone were chosen 
based on the results of  the arachidonic  acid turnover  
studies. 30 rain pr ior  to terminat ing the assay, TMP-DPH 
was added so that the f inal concentrat ion of  the probe was 
10 -7 M. 
Measurements  were carr ied out on an SLM 5000 spec- 
trof luorometer.  Data acquis i t ion was s impl i f ied by interfac- 
ing a personal computer to the signal processing unit of the 
spectrofluorometer. Changes in anisotropy were measured, 
following addition of TMP-DPH, using an excitation 
wavelength of 353 nm and an emission wavelength of 426 
nm. The influence of experimental parameters on anisotro- 
py was determined using the Perrin-Weber equation 
[42,43]. There is a direct correlation between the anisotro- 
py and fluidity (viscosity) of the membrane such that a 
decrease in anisotropy is interpreted as an increase in 
membrane fluidity [44]. Each measurement was corrected 
for contributions due to scattering by measuring these 
components with blanks composed of solution constituents 
minus the fluorophore [45]. 
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Fig. 3. Effect of 17a-estradiol n arachidonic acid turnover by resting 
zone chondrocytes from female rats. Confluent, fourth passage resting 
zone chondrocytes were pre-labeled with [14C]arachidonic a id and then 
treated with varying concentrations of 17ot-estradiol (10-i1_ 10-8 M) for 
30, 90, or 270 rain. Reacylation was blocked in one half of the cultures 
by inclusion of 100 nmol/ml p-chloromercuribenzoate acidincorpora- 
tion. A: percent arachidonic acid release. B: percent arachidonic acid 
incorporation. All values are from one experiment and represent the 
mean + SEM for six samples. Each experiment was repeated two addi- 
tional times to verify the observations. 
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Fig. 4. Effect of 17/3-estradiol n arachidonic acid turnover by growth 
zone chondrocytes derived from female rats. Confluent, fourth passage 
growth zone chondrocytes were pre-labeled with [i4C]arachidonic acid 
and treated as described in Fig. I. A: percent arachidonic acid release. B: 
percent arachidonic acid incorporation. All values are from one experi- 
ment and represent the mean + SEM for six samples. Each experiment 
was repeated two additional times to verify the observations. 
2.6. Statistical analysis 
For analysis of [~4C]arachidonic a id turnover, data are 
expressed as the mean + standard error of the mean (SEM) 
of six cultures. For isolated matrix vesicles and plasma 
membranes, each sample represents the combined mem- 
branes from three T75 flasks. Values are expressed as the 
mean + SEM for six samples. The data presented are from 
representative experiments. However, all experiments were 
performed a minimum of two times using different batches 
of cells to ensure consistency of the observations. The data 
were analyzed by analysis of variance, and statistical sig- 
nificance was determined by comparing each data point to 
the control (containing the ethanol vehicle) using Bonfer- 
roni's t-test. Treatment/control atios were compared us- 
ing the Wilcoxon matched pair rank sum test. P < 0.05 
was considered significant. 
3. Results 
3.1. Arachidonic acid turnover 
The effect of 17/3-estradiol n arachidonic acid turnover 
was dose- and time-dependent, sex-specific, and cell matu- 
ration-specific. Incubation of resting zone chondrocytes 
from female rats with 17fl-estradiol for 30, 90, or 270 min 
produced a significant increase in acylation (release) and 
reacylation (incorporation) of arachidonic acid at 10 -1°- 
10 _9 M hormone (Fig. 1). The basal amount of acylation 
(Fig. I A) and reacylation (Fig. 1B) increased with time, 
but the dose dependence of the 17/3-estradiol effect was 
consistent at each of the time points examined. As indi- 
cated by the treatment/control atios of three separate 
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Effect of 17/3-estradiol on the incorporation and release of 
arachidonic acid by resting zone chondrocytes derived from male rats. 
Confluent, fourth passage resting zone chondrocytes were pre-labeled 
with [14C]arachidonic a id and treated as described in Fig. I. A: percent 
arachidonoic acid release. B: percent arachidonic acid incorporation. All 
values are from one experiment and represent the mean+ SEM for six 
samples. Each experiment was repeated a minimum of two times to verify 
the observations. 
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experiments (Fig. 2), the effect of hormone treatment was 
consistent. By correcting for the time-dependent changes 
in basal arachidonic acid turnover, the treatment/control 
ratios demonstrate that the effects of 17/3-estradiol on 
release were greatest at 30 min and then gradually de- 
clined. The effect on incorporation was also rapid, remain- 
ing at peak levels over the first 2 h. In contrast, 17a- 
estradiol treatment of resting zone chondrocytes from fe- 
male rats had no effect on either acylation (Fig. 3A) or 
reacylation (Fig. 3B) at any of the times or concentrations 
examined. Neither 17/3-estradiol (Fig. 4) nor 17a-estradiol 
(data not shown) had any effect on either arachidonic acid 
release or incorporation i growth zone chondrocytes iso- 
lated from female (Fig. 4) or male (data not shown) rats. In 
addition, arachidonic acid turnover by male resting zone 
chondrocytes was unaffected by either 17/3-estradiol (Fig. 
5) or 17c~-estradiol (data not shown) at any dose or time 
tested. 
3.2. Phospholipase A 2 specific activity 
When matrix vesicles and plasma membranes were 
isolated from female resting zone chondrocyte cultures 
treated with varying concentrations of 17/3-estradiol for 24 
h and assayed for phospholipase A 2 specific activity, it 
was observed that 10-]°-10 -9 M 17/3-estradiol produced 
a significant increase in matrix vesicle enzyme specific 
activity (Fig. 6). In contrast, 17/3-estradiol had no effect on 
the plasma membrane nzyme activity. Similar treatment 
of growth zone chondrocytes from female rats had no 
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Fig. 6. Effect of 17/3-estradiol n phospholipase A 2 specific activity of 
matrix vesicles and plasma membranes i olated from confluent cultures 
of resting zone chondrocytes derived from female rats treated with 
17/3-estradiol for 24 h. All values are from one experiment and represent 
the mean_+ SEM for six samples. Each experiment was repeated two 
additional times to verify the observation. ' P < 0.05, treated vs. un- 
treated control. 
Table 1 
Phospholipase A 2 specific activity in matrix vesicles (MV) and plasma 
membranes (PM) isolated from female rat growth zone chondrocyte 
cultures treated with 17/3-estradiol 
17/3-Estradiol 
(M) 
% Hydrolysis/mg protein/min 
MV PM 
- 0.47 + 0.22 0.47 + 0.10 
10 - i t  0.45_+0.11 0.66+0.10 
10 - t°  0.36_+0.05 0.56_+0.12 
10 -9 0.59+0.11 0.53_+0.12 
10 -8 0.47_+0.12 0.71 -I-0.15 
10 -7 0.45_+0.13 0.40_+0.12 
Data are mean+SEM; n=6 samples, where each sample is the com- 
bined membranes of three cultures. 
effect on phospholipase A 2 specific activity in either the 
plasma membranes or matrix vesicles (Table 1), nor was 
there any effect of 17/3-estradiol on phospholipase A 2 
specific activity of either matrix vesicles or plasma mem- 
branes isolated from cultures of male rat resting zone or 
growth zone cells (data not shown). 
3.3. Membrane fluidity 
When plasma membranes and matrix vesicles were 
isolated from female rat resting zone chondrocyte cultures 
and then incubated irectly with 17/3-estradiol for 30 min, 
there was an increase in anisotropy at 10-1°-10 -9 M 
hormone (Fig. 7A). Although incubation with 10 -8 M 
17/3-estradiol also increased anisotropy relative to unex- 
posed membranes, the effect was not significant. The 
dose-dependent ffect of 17fl-estradiol n membrane fluid- 
ity was consistently observed in all experiments (n = 5), 
although the relative intensity of the response varied (Fig. 
7B). Incubation of plasma membranes and matrix vesicles 
isolated from cultures of male rat resting zone chondro- 
cytes with 17/3-estradiol for 30 min had no effect on 
membrane anisotropy. There was also no effect of 17/3- 
estradiol on the anisotropy of matrix vesicles or plasma 
membranes i olated from cultures of either female or male 
rat growth zone chondrocytes (data not shown). In addi- 
tion, the effect of 17/3-estradiol n membrane fluidity was 
stereo-specific, as 17a-estradiol was without effect (Table 
2). 
The effect of 17/3-estradiol n the membrane fluidity of 
matrix vesicles (Fig. 8A) and plasma membranes (Fig. 8B) 
isolated from female rat resting zone chondrocyte cultures 
was also time-dependent and membrane-specific. During 
the first 20 min of incubation, the anisotropy of untreated 
matrix vesicles decreased, while that of those incubated 
with hormone increased (Fig. 8A). From 30 min through 
180 min, the anisotropy of the treated matrix vesicles was 
consistently greater than that seen in the untreated mem- 
branes, irrespective of changes in the basal levels. By 3 h 
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Fig. 7. Effect of 17fl-estradiol on the membrane fluidity of matrix 
vesicles and plasma membranes i olated from cultures of resting zone 
chondrocytes derived from female rats. Matrix vesicles (MV) and plasma 
membranes (PM) were isolated and treated for 30 rain with varying 
concentrations of 17/3-estradiol (10 -u°  10-s M), TMP-DPH added, and 
the change in anisotropy determined by spectrofluorometry. A: results 
from one representative experiment. B: average treatment:control atios 
for five independent experiments. All values in A represent the mean ± 
SEM for six membrane samples. * P < 0.05, treated vs. untreated con- 
trol. 
of incubation, the anisotropy of treated and untreated 
matrix vesicles was the same. Plasma membrane anisotro- 
py decreased uring the first 20 min of incubation in both 
treated and untreated samples (Fig. 8B). Changes in plasma 
membrane anisotropy, due to the presence of 17/3-estradiol, 
Table 2 
Direct effect of 17a-estradiol n anisotropy of matrix vesicles and plasma 
membranes i olated from female rat resting zone chondrocyte cultures 
Anisotropy 
17a-Estradiol Matrix vesicles Plasma membranes n 
Vehicle only 0.32 ± 0.02 0.38 ± 0.02 6 
10 - t °  M 0.33±0.01 0.37 ± 0.0l 6 
10 -9 M 0.33+0.01 0.39+0.01 5 
10 -8 M 0.31 _+0.02 0.38_+0.01 6 
Data are the mean ± SEM. Each n represents he combined membranes 
from three cultures. 
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Fig. 8. Effect of l T/3-estradiol on the membrane fluidity of matrix 
vesicles and plasma membranes i olated from cultures of female rat 
resting zone chondrocytes over time. Matrix vesicles (A) and plasma 
membranes (B) were isolated and treated for 5-1440 rain with 17/3- 
estradiol (10 -n° M), TMP-DPH added, and the change in anisotropy 
determined by spectrofluorornetry. Control cultures were treated with 
vehicle alone and the assay performed. All values are from one experi- 
ment and represent the mean_+ SEM for six samples. Each experiment 
was repeated two additional times to verify the observations. * P < 0.05, 
treated vs. untreated control. 
were not detected until the membranes had been exposed 
to hormone for 30 min. When these studies were repeated 
three more times, similar results were obtained. Further, 
the oscillation in anisotropy values over time, in both 
treated and untreated membranes, was also consistently 
observed, suggesting that time-dependent fluctuations were 
an inherent characteristic of the membranes and indepen- 
dent of hormone treatment. 
In contrast o the responsiveness of female rat resting 
zone chondrocyte membranes, no change in anisotropy 
was seen in matrix vesicles (Fig. 9) or plasma membranes 
(data not shown) isolated from male rat resting zone 
chondrocyte cultures at any time examined, whether or not 
17/3-estradiol was present. Similarly, there was no effect of 
hormone on the anisotropy of plasma membranes or matrix 
vesicles from cultures of either female or male rat growth 
8 Z Schwartz et al./Biochimica et Biophysica Acta 1282 (1996) 1- I0  
0.8 
ca. 0.6 
0 t.- 
0 
0'} .B  
C 
< 0,3 
Male RC Cell 
Matr ix  Ves ic les  
- -e -  Cont ro l  
-=-" 10" l°M 
--A-- 10"gM T 
.,f 
0.1 I I I I I I I I 
0 5 10 20 30 60 180 3601440 
Time (Minutes) 
Fig. 9. Effect of 17/3-estradiol on the membrane fluidity of matrix 
vesicles isolated from cultures of male rat resting zone chondrocytes over 
time. Matrix vesicles were isolated and treated for 5-1440 rain with 
17/3-estradiol (10-to or 10 -9 M), TMP-DPH added, and the change in 
anisotropy determined by spectrofluorometry. Control cultures were 
treated with vehicle alone and the assay performed. All values are from 
one experiment and represent he mean + SEM for six samples. Each 
experiment was repeated two additional times to verify the observations. 
P < 0.05, treated vs. untreated control. 
zone chondrocytes atany time or dose examined (data not 
shown). 
4. Discussion 
As shown by others [31,32], 17/3-estradiol exerts rapid 
effects on its target cells. The regulation of arachidonic 
acid turnover in chondrocytes by estradiol is rapid, stereo- 
specific, and dose-dependent. Further, the results of this 
study show that these effects are also sex- and cell matura- 
tion-specific and only seen at physiologically relevant 
concentrations. The fact that these rapid effects were lim- 
ited to resting zone chondrocytes derived from female rats 
suggests that the composition of the cell membranes or 
their lipid metabolism is unique. It is possible that the 
classical intracellular estrogen receptor may play a role in 
this; however, our previous tudies have demonstrated that 
receptors are present in both resting zone and growth zone 
chondrocytes from both female and male rats [16]. While 
the number of receptors was greater in the chondrocytes 
derived from female rats, there was no difference as a 
function of cell maturation. Thus, it is unlikely that intra- 
cellular estrogen receptor-mediated events could account 
for all of the observed ifferences. Recently, Pappas et al. 
[33] demonstrated the presence of a membrane receptor for 
estrogen in GH3/B6 rat pituitary cells. If such a receptor 
can be shown to exist in female rat resting zone chondro- 
cytes, it would be an attractive candidate for mediating the 
rapid effects on arachidonic acid turnover observed in this 
study. 
Changes in arachidonic acid turnover could have a 
number of consequences for the cell. By retailoring the 
fatty acid residues of the membrane phospholipids, the cell 
can markedly alter the physical characteristics of the mem- 
brane, resulting in altered fluidity [46-48] and function, 
including ion flux and enzyme activity [22,29,49-51]. 
Released arachidonic acid may contribute to the produc- 
tion of prostaglandins and other autocoid mediators known 
to have a regulatory influence on these cells. Other by- 
products of the acylation reaction can also contribute to 
signal transduction, for example, via protein kinase C 
activation [52,53]. In fact, 17/3-estradiol has been shown to 
increase protein kinase C in GH 3 pituitary cells [54] and to 
enhance ion transport in granulosa cells [31]. 
In addition to the rapid effect on arachidonic acid 
turnover, 17/3-estradiol also exerts a long-term effect on 
membrane phospholipid metabolism. After a 24 h exposure 
to hormone, matrix vesicles produced by resting zone 
chondrocytes derived from female rats exhibited adose-de- 
pendent increase in phospholipase A 2 specific activity. 
These experiments demonstrate he sex specificity (only 
chondrocytes from female rats were affected) and cell- 
maturation dependence (only resting zone chondrocytes 
showed a change in enzyme specific activity) of the action 
of 17/3-estradiol on membrane phospholipid metabolism. 
Moreover, they indicate the membrane selectivity of the 
effect, since only matrix vesicles were affected. 
Our studies confirm those of Reddy et al. [30] demon- 
strating that estradiol alters membrane fluidity in vaginal 
epithelial cells. The action of effector molecules uch as 
proteins, steroids, or other hydrophobic compounds [48,55], 
either via effects on membrane phospholipid metabolism 
like those described in the present study, or simply by the 
physical presence of the effector molecule in the mem- 
brane, may be responsible for changes in membrane fluid- 
ity. Plasma membranes and matrix vesicles isolated from 
cultures of resting zone and growth zone chondrocytes 
differ in their phospholipid composition [27], phospholipid 
metabolism [29,35], and relative distribution of enzyme 
activities [34,56]. Moreover, membranes i olated from cul- 
tures of male rat chondrocytes differ from membranes 
isolated from female rat chondrocytes [8,57]. This suggests 
that plasma membranes and matrix vesicles are structurally 
different and provides a partial rationale for the differences 
in response to both vitamin D metabolites and 17/3- 
estradiol. 
Changes in membrane fluidity, as a function of cell 
maturation, have been reported by others as well. Fluores- 
cence steady-state anisotropy measurements comparing the 
fluidity of plasma membranes of chondrocytes from rest- 
ing and ossifying zones of epiphyseal cartilage indicate 
that considerable modification of the chondrocyte plasma 
membrane occurs as the cells hypertrophy, resulting in 
higher membrane fluidity [51]. It is clear that membrane 
fluidity is also sensitive to the physiological state of the 
cell, since it has been noted that membrane fluidity is 
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altered in several different clinical diseases uch as dia- 
betes [58] and plasmalogen deficiency [39]. It is also 
obvious that changes in membrane fluidity are important 
because the plasma membrane is the locus of early cell 
response to external stimuli [23]. 
The present study supports our prior observations show- 
ing that membrane function can be altered in a differential 
manner by the vitamin D metabolites, 1,25-(OH) 2D 3 and 
24,25-(OH)2D 3. Using matrix vesicles and plasma mem- 
branes from costochondral chondrocytes, the effects of 
these hormones on membrane fluidity were shown to be 
metabolite-specific, membrane-specific, and cell matura- 
tion-specific [27,28,34]. Similarly, the vitamin D metabo- 
lites had a direct effect on phospholipase A 2 activity. 
1,25-(OH)2D 3 stimulates this enzyme in plasma mem- 
branes and matrix vesicles isolated from growth zone 
chondrocytes, whereas 24,25-(OH)2D 3 inhibits this en- 
zyme in membranes i olated from cultures of resting zone 
chondrocytes. Further, both metabolites regulate arachi- 
donic acid turnover, and the effects are cell maturation-de- 
pendent and metabolite-specific. 
The effects of 17/3-estradiol, however, are distinct from 
those of either 1,25-(OH)zD 3or 24,25-(OH) 2D 3 when one 
examines changes in fluidity as a function of time, changes 
in phospholipase A 2 activity, or changes in arachidonic 
acid turnover. This suggests that direct membrane ffects 
may be a general property of steroids and related secos- 
teroid hormones and indicates a function for these hor- 
mones that is independent of the classic hormone receptor 
mediated pathway. Nonetheless, the membrane response to 
lipophilic mediators is specific to the hormone. This is 
supported by the stereospecificity of the 17/3-estradiol 
effect on the fluidity of matrix vesicles from female rat 
resting zone chondrocyte cultures. In addition, the effects 
occur at hormone concentrations lower than would be 
expected if all of the observations were simply the result 
of hormone intercalation in the membrane. Further, since 
the basal chemical composition of the plasma membranes 
and matrix vesicles used to assess the effect of 17/3- 
estradiol was comparable to that of membranes used to 
assess the vitamin D effects, it is likely that specific 
membrane receptors or structural units for each hormone 
exist [22-25]. 
In summary, we have shown that 17/3-estradiol can 
exert a rapid effect on chondrocyte phospholipid 
metabolism that is cell maturation-dependent a d sex- 
specific. In addition, the hormone xerts a long-term effect 
on phospholipid metabolism that is specifically targeted to 
extracellular matrix vesicles, resulting in increased phos- 
pholipase A 2 activity. 17fl-estradiol also exerts a direct, 
sex-specific effect on matrix vesicles and plasma mem- 
branes, evidenced by changes in membrane fluidity. The 
time course of this effect suggests that the alteration in 
fluidity may be secondary to the rapid effect on fatty acid 
acylation. Stereo-selectivity and sex and cell maturation 
dependence of the estradiol response, particularly the 
nongenomic regulation of membrane fluidity in isolated 
matrix vesicles and plasma membranes, uggests a specific 
interaction of 17/3-estradiol with the membrane, potentially 
mediated via a membrane receptor. 
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